We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADPT icon
2976
Adaptive Biotechnologies
ADPT
$3.87B
$59K ﹤0.01%
1,459
-4,401
-75% -$238K
ASC icon
2977
Ardmore Shipping
ASC
$711M
$59K ﹤0.01%
12,813
-6,954
-35% -$28.2K
EWS icon
2978
iShares MSCI Singapore ETF
EWS
$1.17B
$59K ﹤0.01%
2,493
-422
-14% -$9.47K
FMBH icon
2979
First Mid Bancshares
FMBH
$1.39B
$59K ﹤0.01%
1,339
-1,621
-55% -$61.2K
MGPI icon
2980
MGP Ingredients
MGPI
$377M
$59K ﹤0.01%
1,002
-87
-8% -$5.28K
SCHL icon
2981
Scholastic
SCHL
$787M
$59K ﹤0.01%
1,964
+980
+100% +$27.6K
SIEB icon
2982
Siebert Financial
SIEB
$77.7M
$59K ﹤0.01%
14,601
+10,799
+284% +$51.9K
SSTI icon
2983
SoundThinking
SSTI
$82.6M
$59K ﹤0.01%
1,676
-124
-7% -$5.39K
TVTX icon
2984
Travere Therapeutics
TVTX
$5.76B
$59K ﹤0.01%
2,350
+799
+52% +$22.1K
VIRX
2985
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$59K ﹤0.01%
6,386
+5,859
+1,112% +$61K
AVGR
2986
DELISTED
Avinger, Inc. Common Stock
AVGR
$59K ﹤0.01%
131
+55
+72% +$26.4K
HTGM
2987
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$59K ﹤0.01%
906
+25
+3% +$1.9K
TEN
2988
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$59K ﹤0.01%
5,490
-15,278
-74% -$167K
CNR
2989
DELISTED
Cornerstone Building Brands, Inc.
CNR
$59K ﹤0.01%
4,201
-7,882
-65% -$95.5K
ZIXI
2990
DELISTED
Zix Corporation
ZIXI
$59K ﹤0.01%
7,827
-3,696
-32% -$31.1K
AQN icon
2991
Algonquin Power & Utilities
AQN
$4.52B
$58K ﹤0.01%
3,700
+277
+8% +$4.57K
BEEM icon
2992
Beam Global
BEEM
$24.4M
$58K ﹤0.01%
+1,340
New +$70.5K
HSBC icon
2993
HSBC
HSBC
$358B
$58K ﹤0.01%
1,965
-4,193
-68% -$120K
KYMR icon
2994
Kymera Therapeutics
KYMR
$9.54B
$58K ﹤0.01%
1,484
+734
+98% +$44.2K
LPG icon
2995
Dorian LPG
LPG
$1.98B
$58K ﹤0.01%
4,420
+564
+15% +$7.49K
MCS icon
2996
Marcus Corp
MCS
$924M
$58K ﹤0.01%
2,916
+786
+37% +$14.5K
MOD icon
2997
Modine Manufacturing
MOD
$11B
$58K ﹤0.01%
3,920
-8,821
-69% -$125K
PBYI icon
2998
Puma Biotechnology
PBYI
$445M
$58K ﹤0.01%
5,918
-4,962
-46% -$55.4K
RIGL icon
2999
Rigel Pharmaceuticals
RIGL
$787M
$58K ﹤0.01%
1,716
+630
+58% +$24.9K
PRTK
3000
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$58K ﹤0.01%
8,184
-3,665
-31% -$26.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.